Tranzyme Pharma Announces Third Quarter 2012 Financial Results
08 nov. 2012 16h30 HE
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class...
Tranzyme Pharma to Host Third Quarter 2012 Financial Results Conference Call on Friday, November 9, 2012
25 oct. 2012 05h10 HE
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will host a conference call on Friday, November 9, 2012 at 8:30 am ET to discuss...